Elanco Animal Health Incorporated has bid $7.6 billion US to buy Bayer AG’s animal health business.
The deal needs government approval and would create the world’s second-largest animal health company.
It would double Elanco’s pet business and add eight significant products now in Bayer’s research and development pipeline. Bayer has more than 30 animal health products.
“This combination will join two complementary animal health-focused entities previously under the human pharma umbrella into a dedicated company focused on delivering for farmers, veterinarians and pet owners,” said Jeffrey Simmons, president and chief executive officer of Elanco.
“It creates increased speed, attention and investment to bring customers greater access and options . . . to make a difference in the lives of animals,” he said.